Little Known Facts About phenobarbital sodium water solubility.

Little Known Facts About phenobarbital sodium water solubility.

Blog Article

pentobarbital will decrease the level or effect of alprazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.

There aren't any facts on pregnancy exposures in primates equivalent to intervals just before the 3rd trimester in humans.

Contraindicated (1)pentobarbital will lower the level or effect of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is really a sensitive CYP3A4 substrate. Coadministration with potent or reasonable CYP3A4 inducers is contraindicated.

pentobarbital will lessen the level or effect of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Utilization of alternative solutions is strongly recommended when linagliptin is to be administered with a CYP3A4 inducer

Phenytoin, sodium valproate, valproic acid: The effect of barbiturates within the metabolism of phenytoin seems to be variable. Some investigators report an accelerating effect, although others report no effect. As the effect of barbiturates around the metabolism of phenytoin is not read more predictable, phenytoin and barbiturate blood levels must be monitored far more regularly if these drugs are presented concurrently.

pentobarbital will reduce the extent or effect of gefitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will lessen the level or effect of isradipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

Nursing mothers: Caution needs to be exercised any time a barbiturate is administered to your nursing lady considering the fact that tiny amounts of barbiturates are excreted while in the milk.

pentobarbital will enhance the degree or effect of clopidogrel by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.

pentobarbital will decrease the extent or effect of solifenacin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

Watch Closely (1)pentobarbital will lower the level or effect of gefitinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will minimize the level or effect of quinidine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

pentobarbital will reduce the level or effect of cobimetinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Steer clear of coadministration. Sturdy or reasonable CYP3A inducers may possibly lower cobimetinib systemic exposure by >eighty% and cut down its efficacy.

pentobarbital will reduce the level or effect of vardenafil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.